Safety of Live Viral Vaccines in Patients With Chromosome 22q11.2 Deletion Syndrome (DiGeorge Syndrome/Velocardiofacial Syndrome)

PEDIATRICS ◽  
2003 ◽  
Vol 112 (4) ◽  
pp. e325-e325 ◽  
Author(s):  
E. E. Perez ◽  
A. Bokszczanin ◽  
D. McDonald-McGinn ◽  
E. H. Zackai ◽  
K. E. Sullivan
2010 ◽  
Vol 136 (3) ◽  
pp. 409-418 ◽  
Author(s):  
R. Zemble ◽  
E. Luning Prak ◽  
K. McDonald ◽  
D. McDonald-McGinn ◽  
E. Zackai ◽  
...  

2006 ◽  
Vol 140A (8) ◽  
pp. 906-909 ◽  
Author(s):  
Donna M. McDonald-McGinn ◽  
Anne Reilly ◽  
Carina Wallgren-Pettersson ◽  
H. Eugene Hoyme ◽  
Samuel P. Yang ◽  
...  

1998 ◽  
Vol 5 (3) ◽  
pp. 415-417 ◽  
Author(s):  
Christopher A. Smith ◽  
Deborah A. Driscoll ◽  
Beverly S. Emanuel ◽  
Donna M. McDonald-McGinn ◽  
Elaine H. Zackai ◽  
...  

ABSTRACT We wished to determine the prevalence of immunoglobulin A (IgA) deficiency in patients with the chromosome 22q11.2 deletion syndrome. A total of 32 patients with the chromosome 22q11.2 deletion were examined for IgA deficiency. We report a 13% (n = 4) prevalence of IgA deficiency in patients with this syndrome. The odds ratio of IgA deficiency in this population is 14.20 (P< 0.0001). This confirms the occurrence of significant humoral deficits in this predominantly cellular immunodeficiency.


Sign in / Sign up

Export Citation Format

Share Document